Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Thienopyridines in Acute Coronary Syndrome.

Goodwin MM, Desilets AR, Willett KC.

Ann Pharmacother. 2011 Feb;45(2):207-17. doi: 10.1345/aph.1P319. Review.

PMID:
21304037
2.

Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.

Räber L, Klingenberg R, Heg D, Kelbæk H, Roffi M, Tüller D, Baumbach A, Zanchin T, Carballo D, Ostojic M, Stefanini GG, Rodondi N, von Birgelen C, Moschovitis A, Engstrøm T, Gencer B, Auer R, Meier B, Mach F, Lüscher TF, Jüni P, Matter CM, Windecker S; COMFORTABLE and SPUM-ACS Trial Investigators.

JACC Cardiovasc Interv. 2015 Jul;8(8):1064-74. doi: 10.1016/j.jcin.2015.03.023.

3.

MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.

Clemmensen P, Grieco N, Ince H, Danchin N, Goedicke J, Ramos Y, Schmitt J, Goldstein P; MULTIPRAC study investigators.

Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):220-9. doi: 10.1177/2048872614547449. Epub 2014 Sep 2.

PMID:
25182465
4.

Review of prasugrel for the secondary prevention of atherothrombosis.

Spinler SA, Rees C.

J Manag Care Pharm. 2009 Jun;15(5):383-95. Review.

5.

Prasugrel versus clopidogrel: new management strategies for acute coronary syndrome.

Schnapf AJ.

J Cardiovasc Nurs. 2013 Sep-Oct;28(5):483-94. doi: 10.1097/JCN.0b013e31826173ba.

PMID:
22990232
6.

Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.

Greenhalgh J, Bagust A, Boland A, Dwan K, Beale S, Fleeman N, McEntee J, Dundar Y, Richardson M, Fisher M.

Health Technol Assess. 2015 Apr;19(29):1-130. doi: 10.3310/hta19290. Review.

7.

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.

Roe MT, Goodman SG, Ohman EM, Stevens SR, Hochman JS, Gottlieb S, Martinez F, Dalby AJ, Boden WE, White HD, Prabhakaran D, Winters KJ, Aylward PE, Bassand JP, McGuire DK, Ardissino D, Fox KA, Armstrong PW.

Circulation. 2013 Aug 20;128(8):823-33. doi: 10.1161/CIRCULATIONAHA.113.002303. Epub 2013 Jul 12.

8.

Emerging antiplatelet therapies in percutaneous coronary intervention: a focus on prasugrel.

Martin MT, Spinler SA, Nutescu EA.

Clin Ther. 2011 Apr;33(4):425-42. doi: 10.1016/j.clinthera.2011.04.007. Review.

PMID:
21635989
9.

Novel oral P2Y12 inhibitor prasugrel vs. clopidogrel in patients with acute coronary syndrome: evidence based on 6 studies.

Jia M, Li Z, Chu H, Li L, Chen K.

Med Sci Monit. 2015 Apr 20;21:1131-7. doi: 10.12659/MSM.893914.

10.

Prasugrel versus clopidogrel antiplatelet therapy after acute coronary syndrome: matching treatments with patients.

Tcheng JE, Mackay SM.

Am J Cardiovasc Drugs. 2012 Apr 1;12(2):83-91. doi: 10.2165/11594600-000000000-00000. Review.

PMID:
22316323
11.

[Switching from clopidogrel to prasugrel: Efficacy and safety data].

Yamaç AH, Göktekin O.

Turk Kardiyol Dern Ars. 2015 Oct;43 Suppl 2:20-4. Review. Turkish.

12.
13.

Time-Varying Effects of Prasugrel Versus Clopidogrel on the Long-Term Risks of Stroke After Acute Coronary Syndromes: Results From the TRILOGY ACS Trial.

Chin CT, Neely B, Magnus Ohman E, Armstrong PW, Corbalán R, White HD, Prabhakaran D, Winters KJ, Fox KA, Roe MT; TRILOGY ACS Investigators.

Stroke. 2016 Apr;47(4):1135-9. doi: 10.1161/STROKEAHA.115.012454. Epub 2016 Feb 16.

PMID:
26883498
14.

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial.

Nicolau JC, Bhatt DL, Roe MT, Lokhnygina Y, Neely B, Corbalán R, Leiva-Pons JL, Martinez F, Goodman SG, Winters KJ, Verheugt FW, Armstrong PW, White HD, Fox KA, Prabhakaran D, Ohman EM; TRILOGY ACS investigators.

Am Heart J. 2015 Oct;170(4):683-694.e3. doi: 10.1016/j.ahj.2015.05.017. Epub 2015 Jun 11.

PMID:
26386792
15.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
16.

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials.

O'Donoghue ML, Braunwald E, Antman EM, Murphy SA, Bates ER, Rozenman Y, Michelson AD, Hautvast RW, Ver Lee PN, Close SL, Shen L, Mega JL, Sabatine MS, Wiviott SD.

Lancet. 2009 Sep 19;374(9694):989-97. doi: 10.1016/S0140-6736(09)61525-7. Epub 2009 Aug 31. Review.

PMID:
19726078
17.

The cost effectiveness of genetic testing for CYP2C19 variants to guide thienopyridine treatment in patients with acute coronary syndromes: a New Zealand evaluation.

Panattoni L, Brown PM, Te Ao B, Webster M, Gladding P.

Pharmacoeconomics. 2012 Nov 1;30(11):1067-84. doi: 10.2165/11595080-000000000-00000.

PMID:
22974536
18.

[Clopidogrel versus prasugrel in acute coronary syndrome treated with coronary angioplasty].

Lalor N, Rodríguez L, Elissamburu P, Filipini E, Conde D, Nau G, Cura F, Trivi M.

Medicina (B Aires). 2015;75(4):207-12. Spanish.

19.

Use, efficacy and safety of prasugrel in patients with ST segment elevation myocardial infarction scheduled for primary percutaneous coronary intervention in clinical practice. Results of the prospective ATACS-registry.

Zeymer U, Hochadel M, Lauer B, Kaul N, Wöhrle J, Andresen D, Schwimmbeck P, Solzbach U, Thiele H, Gitt A, Diller F, Zahn R.

Int J Cardiol. 2015 Apr 1;184:122-7. doi: 10.1016/j.ijcard.2015.01.047. Epub 2015 Jan 26.

PMID:
25703419
20.

The role of clopidogrel in the management of acute coronary syndromes.

Wodlinger AM, Pieper JA.

Clin Ther. 2003 Aug;25(8):2155-81. Review.

PMID:
14512126
Items per page

Supplemental Content

Write to the Help Desk